---
$id: https://graph.org.ai/products/commodity/51111647
$type: Product
source: UNSPSC
code: "51111647"
title: "Nolatrexed"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nolatrexed

**UNSPSC Code**: 51111647
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a thymidylate synthase inhibitor and folate antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K75ZUN743Q. European Medicines Agency schedules Nolatrexed in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09342MIG. Nolatrexed generally arises in the molecular formula C14H12N4OS. The term NOLATREXED is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 no. 2 1999, list 40.) NOLATREXED is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nolatrexed under HS 29335995 and SITC 51576. As of Q4 2014, NOLATREXED remains the US FDA Preferred Term for this commodity. SMILES: S(C1C2C([NH]C(NC2=O)N)CCC1C)C1CCNCC1.

